I am certainly not calling a top (that would be foolish), but it seems logical to expect some more volatility and further downside if these trend lines are broken by either instrument.
Sarepta Therapeutics Inc
$SRPT is losing a significant trend line on the longer-term time frame. Its next zone of support looks like it will be the convergence of the 50-week moving average and 29.63 level.
Disclosure: No position